Navigation Links
Cephalon Submits Supplemental New Drug Application for FENTORA
Date:11/12/2007

e fatal to a child. Patients and their caregivers must be instructed to keep all tablets out of the reach of children. (See Information for Patients and Caregivers for disposal instructions.)

Due to the higher bioavailability of fentanyl in FENTORA, when converting patients from other oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq(R)), to FENTORA, do not substitute FENTORA on a mcg per mcg basis. Adjust doses as appropriate. (See DOSAGE AND ADMINISTRATION.)

FENTORA is intended to be used only in the care of opioid tolerant cancer patients and only by healthcare professionals who are knowledgeable of and skilled in the use of Schedule II opioids to treat cancer pain.

The concomitant use of FENTORA with strong and moderate cytochrome P450 3A4 inhibitors may result in an increase in fentanyl plasma concentrations, and may cause potentially fatal respiratory depression.

Full prescribing information about FENTORA, including boxed warning, is available from http://www.FENTORA.com.

About Cephalon, Inc.

Cephalon, Inc. is an international biopharmaceutical company, recently inducted into the World Economic Forum Community of Global Growth Companies. For 20 years, the company has been dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. Cephalon has delivered a seven-year compound annual growth rate (CAGR) through 2006 greater than 75% and 2006 revenue of $1.760 billion. A member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota. Cephalon's European headquarters are loca
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
8. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
9. AMDL Submits Data to FDA for Clearance to Market Its DR-70(R) Diagnostic Test to Monitor Colorectal Cancer Patients
10. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
11. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2008)... BioCryst Pharmaceutical...ny will present pre-clinical data on Forodesine HC...he 50th American Society of Hematology (ASH) Annua...co, CA from December 6-9, 2008. Forodesine HCl an...osphorylase (PNP) inhibitors. , , The sched...
(Date:12/5/2008).../PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE...company that identifies, develops and commercializ... today reported that Oncoscience AG, the European ...M BioSciences Inc., has withdrawn its application ...ing authorization of nimotuzumab. Withdrawal of an...
(Date:12/4/2008)...ire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI",...ounced that a single,institutional investor shall...onvertible Senior Notes due 2011 (the "Notes"), wi... The new Notes would have a $32.65 million initi...vision entitling the holder, upon any conversion o...
(Date:12/4/2008)...swire-FirstCall/ -- Favrille, Inc.,(OTC Bulletin ...), a health,information company focused on secure...Records (PHRs), announced today that two significa...efinitive merger agreement have been met. , ...0404/LAF521LOGO ) , "We are pleased to anno...
Breaking Biology Technology:BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition 2BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition 3YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE 2YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE 3Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 2Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 4Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 5
...p to provide travel solution , ,ROCHESTER, Wis. ...s, Inc. announced Monday the formation of an excl...ill deliver benchmarking information to travel man...ester-based Runzheimer, an international consultin... cost benchmarking information, will be helping to...
...about more than the one that got away , , ,Dr. ...WAUKEE The Medical College of Wisconsin is expa... its research. It reached an important milestone J...rector of marketing and licensing for MCW,s Resea... and entrepreneur, Clark understands first hand th...
...race ,Source: UW Communications MADISON - With the...t of Administration on the verge of creating two s...pped in and asked them to combine their efforts. ,...ied nework rather than creating two," said Doyle s...last year about a unified network crumbled when th...
... Area Technical College is offering a new certifi...er Information Systems Department this fall. The C...m a $210,000 grant from the National Science Found... represents a slice of a $3 million-dollar NSF end...te region of Illinois, Ohio, Michigan, Minnesota a...
Other Biology Technology:Runzheimer and Concur develop travel management service 2Interview with Medical College of Wisconsin Research Foundation's new director of marketing and licensing 2Interview with Medical College of Wisconsin Research Foundation's new director of marketing and licensing 3Governor tells state, university to work together on IT 2
(Date:12/3/2008)...first 5-year forest inventory report for Oregon,s ...ublic: Oregon,s Forest Resources, 2001-2005: Five-...e are some key findings from the report:, , Ore...alf of Oregon,s total land area of 61 million acre... particularly near urban areas. The rate of conver...
(Date:12/3/2008)...f Oceanography at UC San Diego returning from rese...nted details of vibrant sea life and ecosystems in...of new species and marine animals previously never...urveys at unexplored depths, have revealed disturb...that human impacts have stretched down deeply in t...
(Date:12/3/2008)...ective gene into mouse blood cells, scientists at ...ted sickle cell disease pathology. In their studie...wed essentially no difference from normal mice. Al...ne therapy to humans presents significant technica...l become an important treatment for the disease. ,...
(Date:12/3/2008)...how a technique using lasers could be employed to ...aign supports one of the main objectives of the ca...E (Advanced Space Carbon and climate Observation o...Explorer missions that has just completed assessme...r five, will be presented to the science community...
Breaking Biology News(10 mins):Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 2Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 4Gene therapy corrects sickle cell disease in laboratory study 2Gene therapy corrects sickle cell disease in laboratory study 3ESA tests laser to measure atmospheric carbon dioxide 2ESA tests laser to measure atmospheric carbon dioxide 3Research May Help Predict Preeclampsia 27479 1Research May Help Predict Preeclampsia 27479 2Research May Help Predict Preeclampsia 27479 3Research May Help Predict Preeclampsia 27479 4US Oncologys Innovent Oncology Division Announces First Agreement Between Rocky Mountain Cancer Centers and Colorado Public Employees Retirement Assoc 27476 1US Oncologys Innovent Oncology Division Announces First Agreement Between Rocky Mountain Cancer Centers and Colorado Public Employees Retirement Assoc 27476 2The Most Ordinary Things Can Cause the Most Extraordinary Eye Injuries Says the Oklahoma Academy of Ophthalmology 27472 1The Most Ordinary Things Can Cause the Most Extraordinary Eye Injuries Says the Oklahoma Academy of Ophthalmology 27472 2The Most Ordinary Things Can Cause the Most Extraordinary Eye Injuries Says the Oklahoma Academy of Ophthalmology 27472 3The Most Ordinary Things Can Cause the Most Extraordinary Eye Injuries Says the Oklahoma Academy of Ophthalmology 27472 4Caltech engineers build firast ever multi input plug and play synthetic RNA device 5440 1Caltech engineers build firast ever multi input plug and play synthetic RNA device 5440 2
...blood of pregnant women appear to indicate the sub...ening complication of pregnancy, report a team of ... and Beth Israel Deaconess Medical Center. The pr...on of blood vessels, also signal the development o...dings appear in the September 7 New England Journa...
...linois at Chicago College of Pharmacy are attempti...ipsychotic medication works in adults and children..., a popular "atypical" antipsychotic medication, i...enia and bipolar disorder. , Jeffrey Bishop, ass...g the effects of one gene, catechol-o-methyltransf...
...sconsin School of Medicine and Public Health (SMPH...r the development of drugs to destroy tumors cause...lished in the Sept. 4 Proceedings of the National ...y of a critical segment of a viral protein require...ound that when they blocked this activity, the vir...
...s Disease Laboratory at Columbia University Mailma...the WHO Global Laboratory Network have developed a...the GreeneChip System. The GreeneChip is the firs...nosis of infectious diseases, including those caus...addition, it is the first tool that can be used on...
Other Biology News:Molecules in blood foretell development of preeclampsia 2Molecules in blood foretell development of preeclampsia 3Molecules in blood foretell development of preeclampsia 4Studies look at how genes affect antipsychotic drug response 2Clue found to Epstein-Barr virus' ability to form and sustain tumors 2'GreeneChip' -- New diagnostic tool that rapidly and accurately identifies multiple pathogens 2'GreeneChip' -- New diagnostic tool that rapidly and accurately identifies multiple pathogens 3
...rokinase (rEK) is a highly purified preparation of...erine protease which recognizes the identical clea...and has similar enzymatic activity (1). Novagen&'s...ld the highest activity available, and is qualifie...
Angiotensin Converting Enzyme [Porcine Kidney, ACE, Peptidyl-dipeptidase A]
The bench-top stand comfortably holds up to 6 Finnpipette Digital single- and multichannel pipettes. The crossbars are made of a grippy material to keep the pipettes firmly in place. Individual shelf
...ase-2A (PPase-2A) is a serine/threonine phosphatas...ted as the heterodimer of 60kDa (A) and 36kDa (C) ...e a-subunit of phosphorylase kinase. With its 3638...e specificity and may play a regulatory role in DN...
Biology Products: